Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Hefti-LF Tablet

Prescription Icon
Prescription Required

Marketer

Zuno Pharmaceuticals

Salt Composition

Artemether (80mg) + Lumefantrine (480mg)

Overview Hefti-LF Tablet

Malarone-equivalent tablets treat malaria in adults and children. This dual-action medication comprises two antimalarial drugs. It's effective against malaria parasites, halting infection spread, but isn't for malaria prevention or severe cases involving organ complications (brain, lungs, kidneys). For optimal absorption, take with food, following your doctor's prescribed dosage and duration. Exceeding the recommended dose is unsafe. Complete the entire course for effective treatment. Common side effects include headache, appetite loss, fatigue, and muscle or joint pain; dizziness may also occur. Report persistent or worsening symptoms to your physician. Disclose all current medications to your doctor before use. Pregnant or lactating individuals should only use this medication under strict medical supervision due to potential fetal harm.

Uses of Hefti-LF Tablet

Managing Malaria Infection

Major Benefits of Hefti-LF Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Hefti-LF Tablets should be administered with a meal.

Common Side effects of Hefti-LF Tablet:

  • Headache
  • Loss of appetite
  • Dizziness
  • Weakness
  • Joint pain
  • Muscle pain

How to use Hefti-LF Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Hefti-LF Tablet with a meal.

How Hefti-LF Tablet works:

Artemether and lumefantrine, the active components of Hefti-LF Tablets, offer a dual-action approach to malaria treatment. By elevating blood heme concentrations, a substance harmful to the malaria parasite, this combination effectively eliminates the parasite and halts disease progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Hefti-LF Tablet lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Hefti-LF Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The use of Hefti-LF Tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Taking Hefti-LF Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if such effects are experienced.

KidneyKidneyCAUTION

Exercise caution when administering Hefti-LF Tablets to individuals with severe renal impairment; dosage modification might be necessary. Physician consultation is advised. Severe kidney disease does not necessitate dosage alteration.

LiverLiverCAUTION

Patients with severe hepatic impairment should use Hefti-LF Tablets cautiously. Dosage modification for Hefti-LF Tablets may be necessary; physician consultation is advised. Severe hepatic impairment does not necessitate dosage alteration.

What if you forget to take Hefti-LF Tablet :

Should you forget a Hefti-LF Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Hefti-LF Tablet

LabelValue
Developing Habits No.
Treatment Category Antimalarial Medications

FAQs on Hefti-LF Tablet

Take Hefti-LF Tablets with food, following your doctor's instructions precisely. A typical regimen involves two doses daily with meals for three days. Begin with the first dose with food, followed by a second dose eight hours later. Subsequently, take one dose in the morning and one in the evening for the remaining two days. To maximize absorption, resume normal eating as soon as you can tolerate food.
Hefti-LF Tablets are not recommended for women during their first trimester of pregnancy due to an increased risk of miscarriage.
Hefti-LF Tablets are contraindicated in patients hypersensitive to any component. Caution is advised for severe malaria and during the first trimester of pregnancy.
Keep this medication in its original, tightly closed container. Store it out of children's reach, at room temperature, and away from excessive heat and moisture.
Hefti-LF Tablet
152